logo

For the Inventor, By the Inventor

King of Prussia, PA, United States of America

Matthew David Kowalski

This inventor holds 9 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Viiv Healthcare Company. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew David Kowalski. Retrieved from https://idiyas.com/inventor/matthew-david-kowalski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • King of Prussia, PA (US) (2014)
  • Research Triangle Park, NC (US) (2015 - 2020)

Company Filing History:

goldMedal9 out of 43 
 
Viiv Healthcare Company
 patents

Years Active: 2014-2020

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 10654871 - Process for preparing (3S,11aR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide (2020-05-19),
2. 10654870 - Process for preparing substituted pyridinones as intermediates in the preparation of polycyclic carbamoylpyridone derivatives (2020-05-19),
3. 10647728 - Process for preparing (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-Hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid (2020-05-12),
4. 10233196 - Process for preparing substituted pyridinones as intermediates in the preparation of polycyclic carbamoylpyridone derivatives (2019-03-19),
5. 10174051 - Substituted pyridinones as intermediates in the preparation of polycyclic carbamoylpyridone derivatives (2019-01-08),
6. 9938296 - Process for preparing (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide (2018-04-10),
7. 9643981 - Process for preparing (4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide (2017-05-09),
8. 9120817 - Process for preparing (4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1' ,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid (2015-09-01),
9. 8889877 - Processes for preparing pyridinone carboxylic acid aldehydes (2014-11-18),

Title: The Innovative Journey of Matthew David Kowalski

Introduction: Matthew David Kowalski, a talented inventor based in King of Prussia, PA (US), has made significant contributions to the field of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Matthew David Kowalski holds several patents in various industries, including technology, healthcare, and consumer goods. His recent patents focus on cutting-edge solutions for everyday challenges, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his career, Matthew David Kowalski has demonstrated a passion for pushing the boundaries of what is possible. His innovative spirit has led to the development of groundbreaking products that have improved the lives of many. From concept to execution, he has shown exceptional skills in bringing ideas to life.

Collaborations: Matthew David Kowalski has collaborated with leading companies, research institutions, and universities to further his inventions. These partnerships have not only expanded his network but have also provided valuable insights and resources to enhance the impact of his work.

Conclusion: Matthew David Kowalski's journey as an inventor is a testament to his ingenuity and commitment to driving positive change through innovation. His relentless pursuit of excellence continues to inspire others in the industry, making him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…